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We report the case of a female patient with lymphomatous
pericardial effusion, which was found to be positive for
Mycobacterium tuberculosis by PCR analysis.
A 64-year-old woman presented to the hospital complain-
ing of left hemithorax discomfort and vomiting. Lung aus-
cultation revealed diminished breath sounds at both bases,
heart auscultation revealed low cardiac valve tones. The
patient was afebrile, while liver, spleen, and peripheral
lymph nodes were not palpable. Examination of the skin
revealed a small number of abdominal subcutaneous
nodules. An echocardiograph revealed pericardial effusion
and the patient was admitted. Pericardiocentesis produced
500 ml of fluid, which was sent for analysis and culture as
well as PCR analysis for M. tuberculosis. One of the sub-
cutaneous nodules was removed and sent for histological
analysis.
On laboratory analysis, peripheral blood values were:
hematocrit 34.1%, mean corpuscular volume 91.7 fl, hemo-
globin 11.1 g/dl, white blood cells (WBC) 7.4  109/l (neu-
trophils 6.0  109/l, lymphocytes 0.755  109/l, eosinophils
0.1  109/l, monocytes 0.5  109/l), platelets 318  109/l,
erythrocyte sedimentation rate 48 mm/h, glucose 135 mg/
dl, creatinine 0.5 mg/dl, total bilirubin 1.12 mg/dl, lactate
dehydrogenase (LDH) 918 U/l, C-reactive protein 3.63 mg/
dl, total protein 5.4 g/dl, albumin 3.2 g/dl. Pericardial fluid
values were: red blood cells 800  109/l, WBC 50  109/l
(neutrophils 4%, lymphocytes 2%, undetermined 94%), glu-
cose 7 mg/dl, LDH 12 000 U/l, albumin 4.6 g/dl, cholesterol
143 mg/dl.
A tuberculin skin test was negative. Autoimmune and
tumor markers were normal. Viral serology (hepatitis B,
cytomegalovirus, Epstein—Barr virus, HIV) was negative.
Pericardial fluid demonstrated negative Ziehl—Nielsen stain-
ing. Cultures of pericardial fluid were negative for micro-
organisms including M. tuberculosis. A sample was sent forcytological examination. A chest computed tomography scan
demonstrated the presence of pericardial effusion and minor
pleuritic effusion, withoutdenopathy.
Pericardiocentesis was performed twice more, and all
three samples of fluid presented positive for M. tuberculosis
by PCR. The Amplicor PCR assay was used (Roche Molecular
Systems), with which the optical density at 450 nm was
>0.400 in all three specimens. Anti-tuberculosis treatment
was initiated (streptomycin, rifampin, isoniazid, and etham-
butol). At this point we must stress that the patient had no
prior history of tuberculous infection.
The skin biopsy demonstrated infiltration with atypical
CD20(+) lymphocytes, indicating high malignancy diffuse B-
cell lymphoma. Cytology of the pericardial effusion indi-
cated the same neoplastic cells. The patient, parallel to
anti-tuberculosis therapy, was started on a CHOP (cyclo-
phosphamide, doxorubicin, vincristine, prednisolone) che-
motherapeutic regimen. After six treatment cycles the
patient was in remission and without pericardial effusion.
Pericardial effusion due to non-Hodgkin lymphoma (NHL)
is uncommon, presenting in less than 1% of cases.1 Moreover,
tuberculous pericarditis is rare, occurring in 1% of cases.2
PCR in pericardial effusion may provide the diagnosis of
pericardial tuberculosis when other clinical indicators are
absent and cultures are negative.3—5 The sensitivity and
specificity of PCR-based assays for M. tuberculosis are
reported to be excellent at 90—98% and>98%, respectively,
although sensitivity for specimens without acid-fast bacilli
seen on direct microscopic examination may be as low as
46%.6,7 In the case presented here, the pericardial effusion
proved positive forM. tuberculosis using the PCR method on
three separate occasions, and this was considered adequate
to initiate anti-tuberculosis therapy, despite the negative
culture.
The presence of M. tuberculosis in lymphomatous peri-
cardial effusion in the case presented herein was probably
due to lymphoma-related immunosuppression, a condition
that is documented.8 Lymphomatous pericardial effusion
Correspondence 565should consistently be analyzed for M. tuberculosis and
treated accordingly.
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Chaiwarith et al. made the observation that compared to HIV
viral load, CD4 count measurements showed a sensitivity of
only 13.3% for detecting antiretroviral failure.1 The authors
also noted a low positive predictive value of the CD4 count for
antiretroviral treatment failure of 8.6%, which was signifi-
cantly lower than clinical criteria. This is an important finding
indicating that there may be causes for low CD4 counts in HIV
patients on antiretroviral treatment different from HIV-
induced immune suppression.
The causes of low CD4 counts without virological failure
require further analysis. The decision to discontinue prophy-
laxis against opportunistic infections for patients on antire-
troviral treatment depends on the CD4 count. Malnutrition
can suppress CD4 counts with preserved immune function.2
Other causes of lymphopenia may be the antiretroviral drugs
themselves: zidovudine exposure in uninfected infants has
been associated with low CD4 counts.3 Patients on tenofovir
and didanosine with complete suppression of viral replication
have previously been shown to have a paradoxical CD4+
decline, attributed to an imbalance of adenosinemetabolites
in this cell population.4 In future studies, adjustment for
body mass index and side effects of antiretroviral drugs may
improve the use of CD4 counts as a tool for monitoring
immune function and the success of antiretroviral treatment.
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